Cbdmd announces publication of human clinical trial data

Charlotte, north carolina--(newsfile corp. - june 27, 2024) -  cbdmd, inc. (nyse american: ycbd) (nyse american: ycbd-pa) (the "company"), one of the nation's leading providers of premium cannabidiol (cbd) products, today announced the publication of the company's human clinical trial data demonstrating the benefits of its proprietary broad spectrum cbd blend. the data was published in the journal of the international society of sports nutrition.
YCBD Ratings Summary
YCBD Quant Ranking